Brooks Laboratories

Brooks Laboratories Limited is a pharmaceutical manufacturing company in India, operating on a contract basis and using its own marketing team for the critical care segment. The company aims to make a difference by using an integrated approach, collaborating with clinicians to provide medicines that lead to optimal patient treatment outcomes. Its mission is to support company goals by nurturing a positive, engaging work environment that responds to the changing needs of the organization and society. Its Critical Care Division, established in 2018, operates a robust distribution network, delivering high-quality injectables to hospitals and healthcare institutions across India. The company's international strategy maintains a pivotal focus on growth through partnerships and B2B models in LATAM and certain African regions. This expansion was driven by a significant 38.64% increase in domestic sales and a remarkable 111.01% growth in exports in FY 2023-24.;